Gemini Therapeutics Stock Shares Outstanding
| GMTXDelisted Stock | USD 17.95 0.05 0.28% |
Gemini Therapeutics fundamentals help investors to digest information that contributes to Gemini Therapeutics' financial success or failures. It also enables traders to predict the movement of Gemini Stock. The fundamental analysis module provides a way to measure Gemini Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gemini Therapeutics stock.
Gemini |
Gemini Therapeutics Company Shares Outstanding Analysis
Gemini Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Gemini Therapeutics Shares Outstanding | 43.33 M |
Most of Gemini Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gemini Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Gemini Therapeutics has 43.33 M of shares currently outstending. This is 76.0% lower than that of the Healthcare sector and 59.45% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 92.42% higher than that of the company.
Gemini Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gemini Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gemini Therapeutics could also be used in its relative valuation, which is a method of valuing Gemini Therapeutics by comparing valuation metrics of similar companies.Gemini Therapeutics is currently under evaluation in shares outstanding category among related companies.
Gemini Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | -0.19 | |||
| Current Valuation | (34.25 M) | |||
| Shares Outstanding | 43.33 M | |||
| Shares Owned By Insiders | 0.24 % | |||
| Shares Owned By Institutions | 87.52 % | |||
| Number Of Shares Shorted | 1.47 M | |||
| Price To Book | 0.68 X | |||
| EBITDA | (69.48 M) | |||
| Net Income | (71.87 M) | |||
| Cash And Equivalents | 108.66 M | |||
| Cash Per Share | 2.51 X | |||
| Total Debt | 404 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 17.58 X | |||
| Book Value Per Share | 2.42 X | |||
| Cash Flow From Operations | (59.7 M) | |||
| Short Ratio | 54.62 X | |||
| Earnings Per Share | (1.58) X | |||
| Target Price | 1.5 | |||
| Number Of Employees | 24 | |||
| Beta | -0.12 | |||
| Market Capitalization | 58.49 M | |||
| Total Asset | 140.44 M | |||
| Z Score | 86.4 | |||
| Net Asset | 140.44 M |
About Gemini Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gemini Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gemini Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gemini Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gemini Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gemini Therapeutics' short interest history, or implied volatility extrapolated from Gemini Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Gemini Stock
If you are still planning to invest in Gemini Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemini Therapeutics' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |